GSK vs OPRX · P/E 13, $103.31B cap vs rev $40.3M
GlaxoSmithKline PLC ADR (GSK) versus OPTIMIZERx Corp (OPRX) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
OPTIMIZERx Corp (OPRX) is a health information services company listed on US.
GSK does not have a complete income-statement cache yet.
Latest reported OPRX revenue for 2026-06-30 was $40.3M. Net income was -$1.2M. OPRX currently screens at market cap $234.9M.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. OPRX currently screens at market cap $234.9M.
Not investment advice. Open the GSK and OPRX stock pages for the full models.
Not investment advice.